142 related articles for article (PubMed ID: 11119139)
1. Microinvasive lobular carcinoma of the breast.
Howat AJ; Armour A; Ellis IO
Histopathology; 2000 Nov; 37(5):477-8. PubMed ID: 11119139
[No Abstract] [Full Text] [Related]
2. [Lobular carcinoma-in-situ and ductal hyperplasia of breast].
Fu L
Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):4-7. PubMed ID: 16608640
[No Abstract] [Full Text] [Related]
3. [Receptor (ER, PgR) levels as prognostic factors in the endocrine therapy of pre- and post-menopausal patients with stage III infiltrative ductal and lobular cancer of the breast].
Calzada L; Salazar EL; Pedron Nuevo N
Ginecol Obstet Mex; 1996 Mar; 64():135-9. PubMed ID: 8729191
[TBL] [Abstract][Full Text] [Related]
4. Lobular carcinoma in situ with microinvasion.
Nemoto T; Castillo N; Tsukada Y; Koul A; Eckhert KH; Bauer RL
J Surg Oncol; 1998 Jan; 67(1):41-6. PubMed ID: 9457256
[TBL] [Abstract][Full Text] [Related]
5. The ductal phenotypic expression of the E-cadherin/catenin complex in tubulolobular carcinoma of the breast: an immunohistochemical and clinicopathologic study.
Esposito NN; Chivukula M; Dabbs DJ
Mod Pathol; 2007 Jan; 20(1):130-8. PubMed ID: 17143261
[TBL] [Abstract][Full Text] [Related]
6. Benign proliferative lesions and in situ carcinoma of the breast: new immunohistological findings and their biological implications.
Böcker W; Bier B; Ludwig A; de Hesselle B; Gerdes J
Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():41-9. PubMed ID: 7507748
[No Abstract] [Full Text] [Related]
7. Distinctive biology of pleomorphic lobular carcinoma of the breast.
Moe RE; Anderson BO
J Surg Oncol; 2005 May; 90(2):47-50. PubMed ID: 15844193
[No Abstract] [Full Text] [Related]
8. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant tamoxifen alone: patterns of recurrence.
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Stitt L
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):117-23. PubMed ID: 9747828
[TBL] [Abstract][Full Text] [Related]
9. Alternative therapy for elderly patients with breast cancer.
von Rueden DG; Sessions SC
Am Surg; 1994 Jan; 60(1):72-8. PubMed ID: 8273979
[TBL] [Abstract][Full Text] [Related]
10. Biological profile of in situ breast cancer investigated by immunohistochemical technique.
Albonico G; Querzoli P; Ferretti S; Rinaldi R; Nenci I
Cancer Detect Prev; 1998; 22(4):313-8. PubMed ID: 9674874
[TBL] [Abstract][Full Text] [Related]
11. Axillary tumour.
Martins A; Serrão V; Fiadeiro T; Lopes MP; Campos F; Pereira H; Rodrigues JC
Histopathology; 2008 Apr; 52(5):654-5. PubMed ID: 18312349
[No Abstract] [Full Text] [Related]
12. Prognostic role of human epidermal growth factor receptor 2 status in premenopausal early breast cancer treated with adjuvant tamoxifen.
Meattini I; Livi L; Saieva C; Franceschini D; Scotti V; Mangoni M; Loi M; Di Brina L; Zei G; Bonomo P; Greto D; Gelain E; Nori J; Sanchez LJ; Orzalesi L; Bianchi S; Biti G
Clin Breast Cancer; 2013 Aug; 13(4):247-53. PubMed ID: 23684167
[TBL] [Abstract][Full Text] [Related]
13. Lobular carcinoma in situ of the breast: results of a radiosurgical conservative treatment.
Cutuli B; Jaeck D; Renaud R; Rodier JF
Oncol Rep; 1998; 5(6):1531-3. PubMed ID: 9769400
[TBL] [Abstract][Full Text] [Related]
14. MR imaging features of invasive breast cancer correlated with hormonal receptors: does progesterone receptor matter?
Chen JH; Nalcioglu O; Su MY
Ann Oncol; 2008 May; 19(5):1024-6. PubMed ID: 18375524
[No Abstract] [Full Text] [Related]
15. Receptors for estrogen and progesterone in breast carcinoma in situ.
Pallis L; Wilking N; Cedermark B; Rutqvist LE; Skoog L
Anticancer Res; 1992; 12(6B):2113-5. PubMed ID: 1295456
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and morphological features and treatment for lobular breast cancer].
Tabagua TT; Semiglazov VV; Bus'ko EA; Semiglazova TIu; Voroshnikov VV
Vopr Onkol; 2013; 59(3):386-9. PubMed ID: 23909043
[TBL] [Abstract][Full Text] [Related]
17. Hormone status of in-situ cancer in BRCA1 and BRCA2 mutation carriers.
Osin P; Crook T; Powles T; Peto J; Gusterson B
Lancet; 1998 May; 351(9114):1487. PubMed ID: 9605807
[No Abstract] [Full Text] [Related]
18. [Therapeutic targeting in breast cancer].
Penault-Llorca F
Ann Pathol; 2009 Nov; 29 Spec No 1():S71-3. PubMed ID: 19887259
[No Abstract] [Full Text] [Related]
19. Biological staging of incipient, in situ, and invasive breast carcinomas.
Querzoli P; Albonico G; Ferretti S; Rinaldi R; Nenci I
Ann N Y Acad Sci; 1996 Apr; 784():381-94. PubMed ID: 8651586
[No Abstract] [Full Text] [Related]
20. PTEN protein expression in postmenopausal steroid receptor positive early breast cancer patients treated with adjuvant tamoxifen.
Milovanovic Z; Dzodic R; Susnjar S; Plesinac-Karapandzic V; Juranic Z; Tatic S
J BUON; 2011; 16(1):46-51. PubMed ID: 21674849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
